Xenon Pharmaceuticals earnings were -$251.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest XENE earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$65.0M, down 1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XENE reported annual earnings of -$234.3M, with 28.5% growth. The next XENE earnings date is Aug 7, 2025.
Xenon Pharmaceuticals Earnings Reports & History FAQ
What were Xenon Pharmaceuticals's earnings last quarter?
On XENE's earnings call on Invalid Date, Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 2025 earnings per share (EPS) of -$0.83, up 33.87% year over year. Total XENE earnings for the quarter were -$65.05 million. In the same quarter last year, Xenon Pharmaceuticals's earnings per share (EPS) was -$0.62.
The next XENE earnings call is Invalid Date. Add XENE to your watchlist to be reminded of Xenon Pharmaceuticals's next earnings date.
Is Xenon Pharmaceuticals profitable or losing money?
As of the last Xenon Pharmaceuticals earnings report, Xenon Pharmaceuticals is currently losing money. Xenon Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$251.45 million, a 33.32% increase year over year.
What was XENE's earnings growth in the past year?
As of Xenon Pharmaceuticals's earnings date in Invalid Date, Xenon Pharmaceuticals's earnings has grown year over year. XENE earnings in the past year totalled -$251.45 million.
What are Xenon Pharmaceuticals's earnings expectations?
The current EPS estimate for Xenon Pharmaceuticals's earnings report in Invalid Date is -$0.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.